Nocturne Acqu Stock Price, News & Analysis

MBTCR NASDAQ

Company Description

Nocturne Acquisition Corporation (symbol: MBTCR) is led by experienced technology and crypto operators, aiming to identify unique, public-ready opportunities. Leveraging deep industry expertise and a vast global network, the company seeks to partner with a crypto or AI tech firm that will drive the next wave of innovation.

The company recently announced a proposed business combination with Cognos Therapeutics, Inc., a medical technology company focusing on developing advanced devices for the treatment of neurological diseases. The merger is expected to bring forth innovative solutions to improve outcomes for patients.

Nocturne, formed in October 2020 as a blank check company, completed its IPO in April 2021. The company is guided by CEO Henry Monzon and CFO Ka Seng (Thomas) Ao, with a vision to facilitate groundbreaking advancements in the tech industry.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

- %

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

August 16, 2023

0.00%

Nocturne Acquisition Corporation Announces Filing of a Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Cognos

acquisition

May 30, 2023

0.00%

Nocturne Acquisition Corporation Announces Receipt of a Second Notification from Nasdaq

acquisition

January 3, 2023

0.00%

Cognos Therapeutics, Inc. to Become Publicly Listed on Nasdaq via Business Combination with Nocturne Acquisition Corporation

acquisition

SEC Filings

View All

No SEC filings available for Nocturne Acqu.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is Nocturne Acquisition Corporation's core focus?

Nocturne aims to identify unique, public-ready opportunities in the technology and crypto sectors.

Who leads Nocturne Acquisition Corporation?

CEO Henry Monzon and CFO Ka Seng (Thomas) Ao lead the company towards innovative partnerships in the tech industry.

What recent announcement did Nocturne make regarding a business combination?

Nocturne recently proposed a business combination with Cognos Therapeutics, Inc., a medical technology company.

When was Nocturne Acquisition Corporation formed?

Nocturne was established in October 2020 as a blank check company and completed its IPO in April 2021.

What is the goal of the proposed merger with Cognos Therapeutics, Inc.?

The merger aims to bring forth innovative solutions for the treatment of neurological diseases.

Who are the key executives at Nocturne Acquisition Corporation?

CEO Henry Monzon and CFO Ka Seng (Thomas) Ao are the key executives driving Nocturne's vision.

What industries does Nocturne Acquisition Corporation operate in?

Nocturne focuses on the technology and crypto sectors to drive the next wave of innovation.

What is the significance of Nocturne's deep industry expertise and global network?

Nocturne leverages its expertise and network to identify cutting-edge opportunities in the market.

What is the expected outcome of the business combination with Cognos Therapeutics, Inc.?

The merger is anticipated to deliver advanced solutions for the treatment of neurological diseases, improving patient outcomes.

How can investors stay informed about Nocturne Acquisition Corporation's developments?

Investors can keep track of the latest news and updates related to Nocturne by following the company's announcements and filings.